Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary Syndrome
Status:
Completed
Trial end date:
2018-06-25
Target enrollment:
Participant gender:
Summary
The purpose of the study was to evaluate whether LIK066 can be developed for the treatment of
polycystic ovary syndrome (PCOS) in overweight and obese women.